Home > M&A deals 2020 > Eyegate Pharmaceuticals, Inc. acquires Panoptes Pharma GES.M.B.H
Add-on Acquistion · Life Science · December 2020

Eyegate Pharmaceuticals, Inc. acquires Panoptes Pharma GES.M.B.H

On December 21, 2020, Eyegate Pharmaceuticals, Inc. acquired Panoptes Pharma GES.M.B.H, a life science company in Austria.

Deal at a glance

AnnouncedDecember 21, 2020 TypeAdd-on Acquistion TargetPanoptes Pharma GES.M.B.H Buyer Eyegate Pharmaceuticals, Inc. SectorLife Science LocationAustria ValueNot disclosed

Target company

Panoptes Pharma GES.M.B.H
Austria
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Eyegate Pharmaceuticals, Inc.
Company · 2 deals on record
  • 1st transaction in life science
  • 1st transaction in Austria
2deals, all time
1in this sector
2020latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Questions about this deal

Who acquired Panoptes Pharma GES.M.B.H?Eyegate Pharmaceuticals, Inc. acquired Panoptes Pharma GES.M.B.H on December 21, 2020.

What type of deal was it?It was a add-on acquistion in the life science sector in 2020.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).